Importantly, overexpressing FTO reverses the aberrant m6A modification of MEG3 and suppresses pyroptosis, highlighting the FTO-MEG3 axis as a potential therapeutic target for stroke intervention (179). The gene discussed is MEG3; the disease is stroke disorder.